Haffkine Bio-Pharmaceutical Corporation Ltd.
Haffkine Bio-Pharmaceutical Corporation Ltd., commonly referred to as Haffkine, is a prominent player in the biopharmaceutical industry, headquartered in Mumbai, India. Established in 1899, the company has a rich history of innovation and excellence, particularly in the fields of vaccine production and biopharmaceuticals. Haffkine is renowned for its core products, which include vaccines for various infectious diseases, as well as a range of diagnostic kits and therapeutic solutions. The company’s commitment to quality and affordability sets it apart in a competitive market. With a strong presence across India and significant operational reach in international markets, Haffkine has achieved notable milestones, including recognition for its contributions to public health. As a trusted name in the biopharmaceutical sector, Haffkine continues to play a vital role in advancing healthcare solutions.
DitchCarbon Score
How does Haffkine Bio-Pharmaceutical Corporation Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Haffkine Bio-Pharmaceutical Corporation Ltd.'s score of 14 is lower than 92% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Haffkine Bio-Pharmaceutical Corporation Ltd.'s reported carbon emissions
Haffkine Bio-Pharmaceutical Corporation Ltd., headquartered in India, currently does not report any carbon emissions data, as there are no available figures for kg CO2e. Additionally, the company has not established specific reduction targets or commitments related to climate initiatives, as indicated by the absence of documented reduction initiatives or climate pledges. As of now, Haffkine Bio-Pharmaceutical Corporation Ltd. does not inherit emissions data from any parent or related organizations, and there are no cascading targets from external sources such as the Science Based Targets initiative (SBTi) or other climate-related frameworks. In the context of the pharmaceutical industry, companies are increasingly focusing on sustainability and carbon reduction strategies. However, without specific data or commitments, Haffkine's current stance on climate action remains unclear.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Haffkine Bio-Pharmaceutical Corporation Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
